Rachel E. Reingold, M., Rose Parisi, M., Guilherme Harada, M., Andrea P. Moy, M., George Dranitsaris, P., Jasmine H. Francis, M., . . . Alexander Drilon, M. Mucocutaneous Adverse Events in Patients With Cancer Treated with the Highly Selective RET Kinase Inhibitor Selpercatinib (LOXO-292). Elsevier.
Chicago Style (17th ed.) CitationRachel E. Reingold, MD, et al. Mucocutaneous Adverse Events in Patients With Cancer Treated with the Highly Selective RET Kinase Inhibitor Selpercatinib (LOXO-292). Elsevier.
MLA (9th ed.) CitationRachel E. Reingold, MD, et al. Mucocutaneous Adverse Events in Patients With Cancer Treated with the Highly Selective RET Kinase Inhibitor Selpercatinib (LOXO-292). Elsevier.
Warning: These citations may not always be 100% accurate.